FDA Approves Vizimpro FDA Approves Vizimpro (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer

FDA Approves Vizimpro FDA Approves Vizimpro (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer September 27, 2018 - Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administra

FDA Approves Emgality

FDA Approves Emgality FDA Approves Emgality (galcanezumab-gnlm) for the Preventive Treatment of Migraine in Adults INDIANAPOLIS, Sept. 27, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration

National Day holiday notice

Regular Bedtime Might Be Key to Better Health

Regular Bedtime Might Be Key to Better Health FRIDAY, Sept. 21, 2018 -- As important as getting close to eight hours of sleep a night is, new research suggests that going to bed and waking up at the same time every day is just as critical for your health

Contact Lenses May Harbor Serious, Blinding Infection

Contact Lenses May Harbor Serious, Blinding Infection FRIDAY, Sept. 21, 2018 -- Contact lens wearers everywhere need to be on the lookout for a rare, but potentially blinding, eye infection, British researchers warn. In southeast England, cases of the

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve Diagnoses FRIDAY, Sept. 21, 2018 -- Every nine minutes, a patient in a U.S. hospital dies because a diagnosis was wrong or delayed -- resulting in 80,000 deaths a year. That sobering estimate comes from the